
Apellis Pharmaceuticals (APLS) Earnings Call Transcripts
Price: $19.61
Market Cap: $2.46B
Avg Volume: 1.93M
Market Cap: $2.46B
Avg Volume: 1.93M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-28 | $-0.37 | $-0.29 |
Read Transcript | Q3 | 2024 | 2024-11-05 | $-0.32 | $-0.46 |
Read Transcript | Q2 | 2024 | 2024-08-01 | $-0.33 | $-0.28 |
Read Transcript | Q1 | 2024 | 2024-05-07 | $-0.54 | $-0.54 |
Read Transcript | Q4 | 2023 | 2024-02-27 | $-0.66 | $-0.73 |
Read Transcript | Q3 | 2023 | 2023-11-01 | $-0.84 | $-1.17 |
Read Transcript | Q2 | 2023 | 2023-07-31 | $-1.35 | $-1.02 |
Read Transcript | Q1 | 2023 | 2023-05-06 | N/A | N/A |
Read Transcript | Q3 | 2022 | 2022-11-08 | N/A | N/A |
Read Transcript | Q2 | 2022 | 2022-08-08 | $-1.43 | $-1.46 |
Read Transcript | Q1 | 2022 | 2022-05-04 | $-1.36 | $-1.42 |
Read Transcript | Q4 | 2021 | 2022-02-28 | $-1.32 | $-1.61 |
Read Transcript | Q3 | 2021 | 2021-11-08 | $-1.73 | $-2.28 |
Read Transcript | Q2 | 2021 | 2021-08-10 | N/A | N/A |
Read Transcript | Q1 | 2021 | 2021-04-29 | N/A | N/A |
Read Transcript | Q4 | 2020 | 2021-02-28 | N/A | N/A |